Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marchex (MCHX) Accumulated Expenses (2019 - 2025)

Marchex (MCHX) has disclosed Accumulated Expenses for 7 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 44.91% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, down 44.91%, while the annual FY2025 figure was $1.2 million, 44.91% down from the prior year.
  • Accumulated Expenses was $1.2 million for Q4 2025 at Marchex, up from $1.0 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $5.1 million in Q1 2021, with the low at $585000.0 in Q1 2025.
  • Historically, Accumulated Expenses has averaged $2.9 million across 5 years, with a median of $3.0 million in 2023.
  • The largest annual shift saw Accumulated Expenses decreased 1.79% in 2022 before it plummeted 62.64% in 2025.
  • Over 5 years, Accumulated Expenses stood at $3.6 million in 2021, then fell by 1.79% to $3.6 million in 2022, then dropped by 7.63% to $3.3 million in 2023, then plummeted by 35.25% to $2.1 million in 2024, then crashed by 44.91% to $1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $1.2 million in Q4 2025, $1.0 million in Q3 2025, and $992000.0 in Q2 2025.